GDS Wealth Management reduced its UnitedHealth Group stake by 10.7% during the third quarter, selling 5,297 shares to end the period with 44,252 shares valued at approximately $15.28 million. Cullen Frost Bankers also trimmed its position by 27.1%, offloading 29,527 shares to hold 79,459 shares worth about $27.44 million. Other smaller institutional moves included new stakes by LFA Lugano Financial Advisors (approximately $25 000), Sagard Holdings Management ($29 000), Grey Fox Wealth Advisors ($33 000) and Islay Capital Management ($31 000). Riggs Asset Management increased its holdings by 69.4% to 105 shares, roughly $33 000. Overall, hedge funds and institutional investors account for 87.86% of UnitedHealth Group’s outstanding shares.

Among covering analysts, one assigns a Strong Buy rating, seventeen maintain a Buy, nine hold at Neutral (Hold) and two recommend Sell, resulting in a consensus rating of Moderate Buy. Recent commentary has focused on potential tailwinds from the upcoming Medicare Advantage 2027 notice, offset by regulatory and cost-pressure concerns. While firms such as Jefferies, Goldman Sachs, UBS and Mizuho have reiterated buy views, Piper Sandler and Morgan Stanley have taken more cautious stances despite keeping overweight ratings.

For the quarter ended October 28, UnitedHealth reported earnings per share of $2.92, exceeding consensus by $0.05. Revenue reached $113.16 billion, essentially in line with consensus expectations. The company delivered a net margin of 4.04% and a return on equity of 19.23%, with revenues up 12.2% year-over-year. Analysts project full-year EPS of 29.54, reflecting confidence in continued top-line growth across UnitedHealthcare and Optum platforms despite near-term margin headwinds.

UnitedHealth declared a quarterly dividend of $2.21 per share, paid December 16 to holders of record on December 8. This equates to an annualized dividend of $8.84 and a yield near 2.5%, supported by a dividend payout ratio of 46.14%. The company’s sustainable free cash flow generation and sub-50% payout ratio underpin management’s ability to maintain or modestly grow distributions over the medium term.